A 2 year old boy presents with abnormal pigmentation around eyes with abnormal eye movements. It is noted that child has spontaneous bursts of non rhythmic conjugate eye movements in various directions. He also suffers from hypotonia and myoclonus. Fuher physical examination reveals an abdominal mass. CT scan is done with the following findings: Which of the following drug is approved for the above clinical scenario?
A 2 year old boy presents with abnormal pigmentation around eyes with abnormal eye movements. It is noted that child has spontaneous bursts of non rhythmic conjugate eye movements in various directions. He also suffers from hypotonia and myoclonus. Fuher physical examination reveals an abdominal mass. CT scan is done with the following findings: Which of the following drug is approved for the above clinical scenario?
💡 Explanation
A 2 year old boy presents with abnormal pigmentation around eyes with abnormal eye movements. It is noted that child has spontaneous bursts of non rhythmic conjugate eye movements in various directions. He also suffers from hypotonia and myoclonus. Fuher physical examination reveals an abdominal mass. CT scan is done with the following findings: Which of the following drug is approved for the above clinical scenario?
✓ Correct Answer: C. Dinutuximab
📤 Share this MCQ
Share Card Preview
👆 1080x1080 square card — fills the full width in WhatsApp and Telegram